This presentation addresses critical gaps in the use of FNA for evaluating lymphadenopathy, emphasizing its potential as a minimally invasive, cost-effective diagnostic tool with the ability to quickly triage patients. Despite its many advantages, diagnosing lymphoma through FNA presents challenges, particularly with paucicellular samples and the need for high-quality specimens and ancillary testing for accurate categorization using recent classification systems. The importance of a multidisciplinary approach and collaboration between cytopathologists and hematopathologists, for enhanced diagnostic accuracy and optimal patient care is emphasized. The goal of the presentation is to empower participants to be able to categorize patients into diagnostic groups with specific risks of malignancy that guide further management decisions rather than striving for definitive WHO/ICC diagnoses.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 100 West 10th Street
Pricing
Typically $26 – $105 per course
the middle half of 66 priced courses listed here
Collected from the provider’s public pages · source
Specialties served/covered
- Anatomic & Clinical Pathology
- Clinical Informatics
- Cytopathology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Otolaryngology
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Medical Leadership & Administration
- Medical Oncology
- Molecular Genetic Pathology
- Obstetrics & Gynecology
- Ophthalmology
- Patient Safety & Quality Improvement
- Pulmonary Disease
- Urology
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.



